CUX1 and myeloproliferative disorder: Mutations in the tumor suppressor Cux1 and RNA splicing factor mutations are associated with MDS/MPD, while strong selection for mutations activating Ras/Raf/MAPK signaling are invariably associated with progression to MPD.